Senators question Allergan CEO on tribe patent deal
Por um escritor misterioso
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
Steven Derringer: Bartlit Beck
Allergan plc
The Loopholes Drug Companies Use to Keep Prices High - Bloomberg
Single-Payer Healthcare Takes a Big Step Forward
Allergan deal with Mohawk tribe casts patent shadow
Allergan's Restasis to Face Impending Generic Competition After Patent License Play Fails - Xtalks
Judge asks if Allergan's patent deal with Mohawk tribe is a 'sham
CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE
Supreme Court case could deal a blow to Mohawk tribe's patent plan
CQ Researcher - Prescription Drug Costs
Notes Archives – Page 4 of 28 – Southern California Law Review
de
por adulto (o preço varia de acordo com o tamanho do grupo)
